HELICID

Main information

  • Trade name:
  • HELICID Gastro-resistant capsule, hard 40MG
  • Dosage:
  • 40MG
  • Pharmaceutical form:
  • Gastro-resistant capsule, hard
  • Administration route:
  • Oral use
  • Units in package:
  • 30 VI Tablet container
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • HELICID Gastro-resistant capsule, hard 40MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • OMEPRAZOLE
  • Product summary:
  • HELICID

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 09/ 313/13-C
  • Last update:
  • 16-01-2018

There are no safety alerts related to this product.

2-10-2018

Nexium Control (Pfizer Healthcare Ireland)

Nexium Control (Pfizer Healthcare Ireland)

Nexium Control (Active substance: esomeprazole) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6474 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/002618/T/0023

Europe -DG Health and Food Safety

27-6-2018

Nexium Control (Pfizer Consumer Healthcare Limited)

Nexium Control (Pfizer Consumer Healthcare Limited)

Nexium Control (Active substance: esomeprazole) - Centralised - Renewal - Commission Decision (2018) 4111 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2618/R/21

Europe -DG Health and Food Safety